AGMB / AgomAb Therapeutics NV - Depositary Receipt (Common Stock) - Net Long/Short Value

AgomAb Therapeutics NV - Depositary Receipt (Common Stock)

AGMB / AgomAb Therapeutics NV - Depositary Receipt (Common Stock) - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Morgan Stanley
UBS Group AG
Laurion Capital Management LP
Goldman Sachs Group Inc
Standard Life Aberdeen plc
LMR Partners LLP
Hrt Financial Lp
Nantahala Capital Management, LLC
Sectoral Asset Management Inc
Samsara BioCapital, LLC
Jane Street Group, Llc
EQT Fund Management S.a r.l.
SBI Securities Co., Ltd.
Redmile Group, LLC
Cormorant Asset Management, LP
Millennium Management Llc
Casdin Capital, LLC
Federated Hermes, Inc.
Bellevue Group AG
Two Sigma Investments, Lp
Seven Grand Managers, Llc
Sanofi
D. E. Shaw & Co., Inc.
Citadel Advisors Llc
Fmr Llc
Burkehill Global Management, LP
Pfizer Inc
Perceptive Advisors Llc
Alyeska Investment Group, L.P.
TCG Crossover Management, LLC
Siren, L.L.C.
Andera Partners
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista